Month: May 2021

TORONTO, May 03, 2021 (GLOBE NEWSWIRE) — Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, is pleased to announce that, in conjunction with the Syscoin Foundation, it has successfully deployed Syscoin LUX, the latest version of the Syscoin blockchain. Syscoin is an open-source blockchain protocol that underpins many of BCF’s proprietary development efforts, and offers fast, highly scalable, and low-cost blockchain infrastructure for a wide variety of applications. Syscoin LUX introduces a range of new features which make Syscoin one of the best and most future-proof decentralized platforms for fungible and non-fungible tokens, payments, and non-custodial, rules-based compliance. Among other innovations, Syscoin LUX brings the following cutting-edge features to life:NFTs:...

AUSTIN, Texas, May 03, 2021 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, will release financial results for the first quarter ended March 31st, 2021 after market close on Wednesday, May 12th, 2021. Management will host a conference call on Wednesday, May 12th, 2021, at 1:30 p.m. Pacific standard time (4:30 p.m. Eastern standard time) to discuss Resonant’s first quarter 2021 financial results. The call will conclude with Q&A from participants. To participate, please use the following information: Q1 2021 Conference Call and WebcastDate: Wednesday, May 12th, 2021Time: 1:30 p.m. Pacific standard time (4:30 p.m. Eastern standard time)U.S. Dial-In: 1-877-423-9813International Dial-In:...

 TDC will conduct a conference call for investors and analysts on May 6, 2021 at 14.30 CET to present the Q1 2021 results. Lasse Pilgaard, Chief Financial Officer, will comment on the results and answer questions during the conference call. The investor and analyst conference will be available in Microsoft Teams at: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YWM1M2I2ZDQtNzdhNC00OWQzLTg2NTgtYzcyZGQxZTdhYzhh%40thread.v2/0?context=%7b%22Tid%22%3a%22e8dcf6e6-3acc-4af9-9cb2-77f688cb688b%22%2c%22Oid%22%3a%22e3bc77b8-3126-4e3f-b136-3297ef0a91d3%22%7d Dial in to Microsoft Teams is: +45 32 72 51 67 – Code: 256 316 081#The conference call will refer to a slide deck that will be available from May 6, 2021 at approx. 10.00 CET on the link: https://tdcgroup.com/en/investor-relations Please mute your microphone before and during the presentation....

SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of awareness initiatives and educational tools highlighting the importance of an accurate and timely diagnosis and patient monitoring for Systemic Lupus Erythematosus (SLE). Emphasizing the patient journey from overlapping symptoms to diagnosis and monitoring, Exagen has launched a new campaign called “Know With AVISE”. Each week in the month of May, Exagen will focus on a step in the patient’s journey with lupus to bring attention to the signs and symptoms of lupus and the issues and challenges people face. In collaboration with the Lupus Foundation of America, Exagen will shed light on the difficulties of diagnosing lupus accurately, as well...

TDC will conduct a conference call for investors and analysts on March 6, 2021 at 14.30 CET to present the Q1 2021 results. Lasse Pilgaard, Chief Financial Officer, will comment on the results and answer questions during the conference call. The investor and analyst conference will be available in Microsoft Teams at: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YWM1M2I2ZDQtNzdhNC00OWQzLTg2NTgtYzcyZGQxZTdhYzhh%40thread.v2/0?context=%7b%22Tid%22%3a%22e8dcf6e6-3acc-4af9-9cb2-77f688cb688b%22%2c%22Oid%22%3a%22e3bc77b8-3126-4e3f-b136-3297ef0a91d3%22%7d Dial in to Microsoft Teams is: +45 32 72 51 67 – Code: 256 316 081#The conference call will refer to a slide deck that will be available from March 6, 2021 at approx. 10.00 CET on the link: https://tdcgroup.com/en/investor-relations Please mute your microphone before and during the...

Appointment adds to the Nanox team extensive experience in global medical business development and sales NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) — NANOX IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. “Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field,” stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. “As we ramp up our manufacturing capabilities...

BURLINGTON, Mass., May 03, 2021 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, will announce its second quarter, fiscal year 2021 financial results for the quarter ended March 31, 2021 on Monday, May 10, 2021 at 7:00 a.m. EST / 4:00 a.m. PST. The company will host a live conference call and webcast, with accompanying slides to discuss the results, on the same day at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time. Interested investors and analysts are invited to dial into the conference call by using 1.844.467.7116 (domestic) or +1.409.983.9838 (international) and entering the pass code 7998527. Webcast access will be available in the Investor Information section of the company’s website at www.cerence.com. The teleconference replay will be available through May 17, 2021. The replay dial-in number is...

CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will host a conference call and webcast on Monday, May 10, 2021 at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2021 and provide business updates.   To access the call, please dial 877-303-9226 (domestic) or 409-981-0870 (international) and provide the Conference ID 5046849. A live webcast of the presentation will be available on the Investors & Media section of the Mersana website at www.mersana.com. About Mersana TherapeuticsMersana Therapeutics is a clinical-stage biopharmaceutical company using...